[Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
Jullien
A M
AM
Fondation Nationale de Transfusion Sanguine, Paris.
Courouce
A M
AM
Maniez
M
M
Brevière
D
D
Menault
M
M
Finetti
P
P
Girard
M
M
D000410:Alanine Transaminase / Q000097:blood*; D015415:Biomarkers; D001782:Blood Donors; D001803:Blood Transfusion / Q000592:standards; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005602:France / Q000453:epidemiology; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000032:analysis / Q000096:biosynthesis; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012307:Risk Factors; D065227:Transfusion Reaction
D015415:Biomarkers; D006508:Hepatitis Antibodies; D000410:Alanine Transaminase
Diminution du risque de transmission du virus de l'hépatite C par les produits sanguins labiles: rôle des marqueurs indirects?